REG - Baronsmead Second VT - Allotment of Shares and Total Voting Rights

Baronsmead Second Venture TrustAnnouncement

Yesterday 11:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250501:nRSA0719Ha&default-theme=true

RNS Number : 0719H  Baronsmead Second Venture Trust PLC  01 May 2025

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR
INDIRECTLY, IN OR INTO, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH
AFRICA,  THE UNITED STATES OR ANY MEMBER STATE OF THE EEA (OTHER THAN ANY
MEMBER STATE OF THE EEA WHERE THE COMPANY'S SECURITIES MAY BE LEGALLY
MARKETED), OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS
ANNOUNCEMENT. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE OR FORM
PART OF ANY OFFER TO ISSUE OR SELL, OR ANY SOLICITATION OF ANY OFFER TO
SUBSCRIBE OR PURCHASE, ANY INVESTMENTS IN ANY JURISDICTION.

 

BARONSMEAD SECOND VENTURE TRUST PLC

 

LEI: 2138008D3WUMF6TW8C28

 

1 May 2025

 

Allotment of Shares and Total Voting Rights

The Board of Baronsmead Second Venture Trust plc (the "Company") announced on
10 January 2025  that the Company, together with Baronsmead Venture Trust
plc, had published a prospectus (the "Prospectus") in relation to offers for
subscription to raise up to £30 million in aggregate with the discretion to
utilise over-allotment facilities to raise up to a further £20 million in
aggregate (the "Offers" and each an "Offer").

On 3 April 2025, the Board announced the decision to extend the period of the
Offer into the 2025/2026 Tax Year, as set out in the Prospectus, with a third
and final allotment to take place on 1 May 2025 at which point the Offer will
close.

Subsequently, the Board decided to extend the Offer to Thursday, 3 July 2025
which was announced on 25 April 2025.  Applications for the final allotment
will need to be received by 9.00 am on Monday, 30 June 2025. All Applications
Amounts must be submitted via bank transfer and funds must have cleared before
the date of allotment.

On 1 May 2025 and in accordance with the Allotment Formula set out in the
Prospectus, the Company allotted 1,186,530 Ordinary Shares of 10 pence each
(the "New Ordinary Shares") in the capital of the Company pursuant to the
Offer conditional only on Admission (the timetable for which is set out in
more detail below). The New Ordinary Shares were issued at prices of between
52.86 pence per New Ordinary Share and 55.28 pence per New Ordinary Share,
depending on the amount of Offer Costs, any Initial Commission waived, any
Initial Adviser Charges, any Early Subscription Incentive associated with an
Application and based on the net asset value per Ordinary Share as at 31 March
2025 (as announced on 29 April  2025, being the last published net asset
value per Ordinary Share). The average issue price was 53.17 pence per share.

Application will shortly be made for the New Ordinary Shares to be admitted to
the Official List of the Financial Conduct Authority and to trading on the
London Stock Exchange plc's main market for listed securities ("Admission").
It is expected that Admission will occur and dealing will commence in the New
Ordinary Shares on or around 8 May 2025. When issued, the New Ordinary Shares
will rank pari passu with the existing Ordinary Shares.

The fourth and final allotment to take place on 3 July 2025 at which point the
Offer will close.

As a result of the issue, the total number of Ordinary Shares in issue will be
463,236,382 (including the 50,243,033 Ordinary Shares currently held in
Treasury) with each Ordinary Share carrying one vote each. Therefore, the
total voting rights in the Company will be 412,993,349. This figure may be
used by shareholders in the Company as the denominator for the calculations by
which they will determine if they are required to notify their interest in, or
a change to their interest in, the share capital of the Company under the
Disclosure Guidance and Transparency Rules.

The New Ordinary Shares will be issued in registered form and may be held in
uncertificated form.  Definitive documents of title are expected to be
dispatched within 10 business days of allotment. The New Ordinary Shares will
be eligible for settlement through CREST with effect from Admission.

Unless the context requires otherwise, terms defined in the Prospectus have
the same meaning where used in this announcement.

For further information please contact:

 

Baronsmead VCT Investor Relations

020 7382 0999

baronsmeadvcts@greshamhouse.com (mailto:baronsmeadvcts@greshamhouse.com)

 

 

Notes

This Announcement is an advertisement for the purposes of the Prospectus
Regulation Rules of the UK Financial Conduct Authority ("FCA") and is not a
prospectus. This Announcement does not constitute or form part of, and should
not be construed as, an offer for sale or subscription of, or solicitation of
any offer to subscribe for or to acquire, any ordinary shares in Baronsmead
Venture Trust plc or Baronsmead Second Venture Trust plc (together the
"Companies") in any jurisdiction, including in or into Australia, Canada,
Japan, the Republic of South Africa, the United States or any member state of
the EEA (other than any member state of the EEA where the Companies'
securities may be lawfully marketed). Investors should not subscribe for or
purchase any ordinary shares referred to in this Announcement except on the
basis of information in the prospectus (the "Prospectus") in its final form,
published on 10 January 2025 by Baronsmead Venture Trust plc and Baronsmead
Second Venture Trust plc, in connection with the Offer. A copy of the
Prospectus  is available for inspection, subject to certain access
restrictions, from the Company's registered office, for viewing at the
National Storage Mechanism at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) and on the Company's
website (http://www.baronsmeadvcts.co.uk (http://www.baronsmeadvcts.co.uk) ).
Approval of the Prospectus by the FCA should not be understood as an
endorsement of the securities that are the subject of the Prospectus.
Potential investors are recommended to read the Prospectus before making an
investment decision in order to fully understand the potential risks and
rewards associated with a decision to invest in the Companies' securities.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IOESSLFSFEISESI